Mastercard Incorporated Third-Quarter 2017 Financial Results Available on Company’s Website

PURCHASE, N.Y.--(BUSINESS WIRE)-- Mastercard Incorporated (NYSE: MA) today announced its financial results for its third quarter of 2017 through an earnings release that is available on the company’s Investor Relations website at www.mastercard.com/investor. The earnings release will be furnished with the Securities and Exchange Commission (SEC) on a Form 8-K and available here.

At 9:00 a.m. ET today, the company will host a conference call to discuss these financial results. The dial-in information for this call is 844-579-6824 (within the U.S.) and 763-488-9145 (outside the U.S.), and the passcode is 92642592. A replay of the call will be available for 30 days and can be accessed by dialing 855-859-2056 (within the U.S.) and 404-537-3406 (outside the U.S.), using passcode 92642592.

This call and all related materials can also be accessed through the Mastercard Investor Relations website at http://investor.mastercard.com/investor-relations/events-and-presentations/default.aspx.

About Mastercard Incorporated

Mastercard (NYSE: MA), www.mastercard.com, is a technology company in the global payments industry. We operate the world’s fastest payments processing network, connecting consumers, financial institutions, merchants, governments and businesses in more than 210 countries and territories. Mastercard products and solutions make everyday commerce activities – such as shopping, traveling, running a business and managing finances – easier, more secure and more efficient for everyone. Follow us on Twitter @MastercardNews, join the discussion on the Beyond the Transaction Blog and subscribe for the latest news on the Engagement Bureau.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171031005777/en/

Mastercard Incorporated
Investor Relations:
Warren Kneeshaw or Jesal Meswani, 914-249-4565
[email protected]
or
Media Relations:
Seth Eisen, 914-249-3153
[email protected]

Source: Mastercard Investor Relations

You May Also Be Interested In

• Vertex to acquire Crinetics Pharmaceuticals for $10 billion
• Context Therapeutics added to Russell 2000 and Russell 3000 indexes
• InMed amends merger deal with Mentari, files S-4 with SEC